Luo L - Search Results

1

High-risk screening of late-onset Pompe disease: A different early portrait in China.

Jiao K, Dong J, Luo S, Yu L, Ke Q, Wang Z, Luan X, Zhang X, Guo J, Chen Y, Li X, Tan S, Qian F, Jiang J, Yu X, Yue D, Liu C, Luo L, Li J, Qu Y, Chen L, Tu J, Sun C, Yan C, Song J, Xi J, Lin J, Lu J, Zhao C, Zhu W, Fang Q. Jiao K, et al. Among authors: luo s, luo l. Front Neurol. 2022 Sep 27;13:965207. doi: 10.3389/fneur.2022.965207. eCollection 2022. Front Neurol. 2022. PMID: 36237614 Free PMC article.

2

5' UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathy.

Xi J, Wang X, Yue D, Dou T, Wu Q, Lu J, Liu Y, Yu W, Qiao K, Lin J, Luo S, Li J, Du A, Dong J, Chen Y, Luo L, Yang J, Niu Z, Liang Z, Zhao C, Lu J, Zhu W, Zhou Y. Xi J, et al. Among authors: luo s, luo l. Brain. 2021 Mar 3;144(2):601-614. doi: 10.1093/brain/awaa426. Brain. 2021. PMID: 33374016

3

Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis.

Zhao R, Wang Y, Huan X, Zhong H, Zhou Z, Xi J, Da Y, Lei L, Chang T, Ruan Z, Luo L, Li S, Yang H, Li Y, Luo S, Zhao C. Zhao R, et al. Among authors: luo s, luo l. J Transl Med. 2021 Jun 30;19(1):285. doi: 10.1186/s12967-021-02961-9. J Transl Med. 2021. PMID: 34193193 Free PMC article.

4

Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets.

Song J, Yang J, Jing S, Yan C, Huan X, Chen S, Zhong H, Lu J, Xi J, Luo L, Chen X, Wang Z, Zhao C, Chu M, Luo S. Song J, et al. Among authors: luo s, luo l. J Neuroimmunol. 2022 Jan 15;362:577787. doi: 10.1016/j.jneuroim.2021.577787. Epub 2021 Dec 11. J Neuroimmunol. 2022. PMID: 34923373

5

Short-term outcome prediction for myasthenia gravis: an explainable machine learning model.

Zhong H, Ruan Z, Yan C, Lv Z, Zheng X, Goh LY, Xi J, Song J, Luo L, Chu L, Tan S, Zhang C, Bu B, Da Y, Duan R, Yang H, Luo S, Chang T, Zhao C; Pan-Yangtze River Delta Alliance for Neuromuscular Disorders (PYDAN). Zhong H, et al. Among authors: luo s, luo l. Ther Adv Neurol Disord. 2023 Feb 24;16:17562864231154976. doi: 10.1177/17562864231154976. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 36860354 Free PMC article.

6

Clinical outcome and peripheral immune profile of myasthenic crisis with omicron infections: A prospective cohort study.

Huan X, Chen J, Zhong H, Xu Y, Wang Y, Jiang H, Song J, Yan C, Xi J, Zou Z, Zheng J, Ruan Z, Tan S, Luo L, Luo S, Zhao C; Pan-Yangtze River Delta Alliance for Neuromuscular Disorders (PYDAN). Huan X, et al. Among authors: luo s, luo l. Clin Immunol. 2024 Feb;259:109879. doi: 10.1016/j.clim.2023.109879. Epub 2023 Dec 22. Clin Immunol. 2024. PMID: 38142901

7

Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1.

Zhong H, Zeng L, Yu X, Ke Q, Dong J, Chen Y, Luo L, Chang X, Guo J, Wang Y, Xiong H, Liu R, Liu C, Wu J, Lin J, Xi J, Zhu W, Tan S, Liu F, Lu J, Zhao C, Luo S. Zhong H, et al. Among authors: luo s, luo l. Orphanet J Rare Dis. 2024 Mar 7;19(1):103. doi: 10.1186/s13023-024-03114-z. Orphanet J Rare Dis. 2024. PMID: 38454488 Free PMC article.

8

Myasthenia-like paraneoplastic syndrome with multiple cranial nerve tumor infiltration: A case report and literature review.

Wen C, Yang J, Xu C, Wei D, Luo L. Wen C, et al. Among authors: luo l. Medicine (Baltimore). 2023 May 19;102(20):e33774. doi: 10.1097/MD.0000000000033774. Medicine (Baltimore). 2023. PMID: 37335736 Free PMC article. Review.

9

FUS mutations in Asian amyotrophic lateral sclerosis patients: a case report and literature review of genotype-phenotype correlations.

Lu T, Yang J, Luo L, Wei D. Lu T, et al. Among authors: luo l. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov;23(7-8):580-584. doi: 10.1080/21678421.2021.2023189. Epub 2022 Mar 1. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 35232295 Review.

10

Anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy treated with ofatumumab.

Wen C, Yang J, Wei D, Xu C, Yu P, Luo L. Wen C, et al. Among authors: luo l. Rheumatology (Oxford). 2024 Feb 1;63(2):e53-e55. doi: 10.1093/rheumatology/kead424. Rheumatology (Oxford). 2024. PMID: 37603718 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,150 results

Search Page